AZN

AstraZeneca
D

AZN

185.010
USD
0.48
(0.26%)
Market Open
Last updated: · Delayed 15 min
Volume
8,204
EPS
10
Div Yield
1.74
P/E
26
Market Cap
286,718,153,350
Related Instruments News

Title: AstraZeneca PLC

Sector: Healthcare
Industry: Drug Manufacturers - General
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Common questions about AstraZeneca stock